Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

August 30, 2024
Otsuka Holdings

Notice regarding Green Bonds Issuance
August 29, 2024
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of October 1, 2024
August 26, 2024
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory to Start Distributing an App "Nurtal" to Visualize Administration of Nutrition and Support Nutrition Management by Healthcare Professionals
August 14, 2024
Otsuka Pharmaceutical

Otsuka Precision Health and Click Therapeutics Announce Launch of Rejoyn, the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms
August 9, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Joins Project to Promote Use of Sustainable Aviation Fuel in Air Cargo Transportation
August 8, 2024
Otsuka Foods

Otsuka Foods to Renew “Bon Curry for Children” A Curry That Supports Parents Who Want Their Children to Eat Well Provides One Full Serving of Japan-Grown Vegetables, Excludes 28 Allergens In Stores across Japan on August 26
August 2, 2024
Otsuka Pharmaceutical

Otsuka and Lundbeck Present New REXULTI® (brexpiprazole) Post Hoc Efficacy Data Analyses for Agitation Associated with Dementia Due to Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2024
August 1, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc. - Transaction Includes JNT-517, a Potential First-In-Class Oral Treatment for Phenylketonuria (PKU) - - Expands Specialty and Autoimmune Portfolios and Drug Discovery Technologies -
July 29, 2024
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory to Build a New Factory "MP-PS" for Stable Supply of Prefilled Syringes
July 23, 2024
Otsuka Pharmaceutical

Free Outdoor Live Music Event "EXCITING SUMMER in WAJIKI 2024" New Heat Illness Prevention and Resource Recycling Initiatives
July 16, 2024
Otsuka Pharmaceutical

Announcement of Price Revisions for Specified Products
July 12, 2024
Otsuka Holdings

Otsuka Holdings Selected as a Constituent of ESG Investment Indexes: FTSE4Good Index Series, FTSE Blossom Japan Index, and FTSE Blossom Japan Sector Relative Index
July 9, 2024
Taiho Pharmaceutical

Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
July 2, 2024
Otsuka Pharmaceutical

Men’s Skincare Brand “UL・OS” Debuts in Taiwan to Contribute to Healthy Skin
July 1, 2024
Taiho Pharmaceutical

Taiho Pharmaceutical Establishes New Company, Arirge Co., Ltd., to Address Social Issues Related to Cancer
June 25, 2024
Otsuka Pharmaceutical

Otsuka and Lundbeck announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD)
June 24, 2024
Otsuka Pharmaceutical

Introducing a New Calorie Mate Block Production Line 　Developing a Sustainable Factory that is Kind to the Environment and Employees
June 18, 2024
Otsuka Pharmaceutical

Otsuka Concludes Expanded Licensing Agreement for Donidalorsen in Hereditary Angioedema, Expanding its Development and Sales Area to Asia Pacific including Japan
June 10, 2024
Otsuka Pharmaceutical

Korea Otsuka Pharmaceutical Launches Soy Bar "SOYJOY" Introducing a New Concept of Healthy Snacking
May 30, 2024
Otsuka Pharmaceutical Taiho Pharmaceutical

Otsuka Pharmaceutical and Taiho Pharmaceutical Commence Material Recycling of Waste PTP Used in Pharmaceutical Packaging
May 29, 2024
Otsuka Pharmaceutical

InnerSignal Introduces a New Basic Skincare Line Launch of “Repair Lotion" and "Repair Milk" to Address Epidermal Imbalance
May 29, 2024
Otsuka Pharmaceutical

Otsuka and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
May 22, 2024
Otsuka Pharmaceutical

Otsuka to Terminate Development of AVP-786
May 22, 2024
Otsuka Pharmaceutical

Novartis launches Entresto® Granular Tablets for Pediatric Use, a formulation dedicated for pediatric patients
May 20, 2024
Otsuka Pharmaceutical

Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
May 8, 2024
Otsuka Pharmaceutical

Carbonated Nutritional Drink "ORONAMIN C DRINK" Debuts in Egypt
April 24, 2024
Otsuka Holdings Otsuka Chemical

Otsuka Group Holds Completion Ceremony for New Cogeneration System and Hydrogen Utilization Facilities Reducing CO2 Emissions With Cutting-Edge Technology
April 23, 2024
Otsuka Medical Devices

Transition of Japanese distribution of Diamondback 360 Coronary Orbital Atherectomy System to Abbott Medical Japan LLC
April 9, 2024
Otsuka Pharmaceutical

Otsuka and Lundbeck submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
April 5, 2024
Otsuka Pharmaceutical

Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry